Skip to search formSkip to main contentSkip to account menu

Ovarian Cystadenocarcinoma

Known as: Cystadenocarcinoma of Ovary, Cystadenocarcinoma of the Ovary 
An adenocarcinoma that arises from the ovary and is characterized by the presence of cystic structures. It includes the serous cystadenocarcinoma… 
National Institutes of Health

Related topics

Related topics

13 relations
Cystic ChangeEndometrial CarcinomaEpithelial CellsEpithelial ovarian cancer

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1996
Review
1996
Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary.
BACKGROUND Steroid receptor status as a prognostic indicator in gynecologic malignancies has been a focus of study for almost 20… 
Highly Cited
1991
Highly Cited
1991
Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo
In vitro and in vivo effects of ginsenoside Rh2 on human ovarian tumor growth were examined by using a cell line (HRA) derived… 
1990
1990
Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
1987
1987
CA 125 antigen in human amniotic fluid and fetal membranes
1985
1985
Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary.
We have identified a case of serous cystadenocarcinoma of the ovary in which the tumor cells display an amplification (from 10… 
1982
1982
Tumor markers in inclusion cysts of the ovary
The immunoperoxidase method was used to determine whether carcinoembryonic antigen, beta subunit of HCG placental lactogen… 
1978
1978
Bullous pemphigoid and ovarian cystadenocarcinoma. Immunologic studies.
A patient with bullous pemphigoid and papillary serous cystadenocarcinoma of the ovary was studied to determine if patient tumor… 
Highly Cited
1973
Highly Cited
1973
Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor‐associated antigens
Evidence is presented for the presence of a tumor‐specific (associated) antigen(s) in human serous cystadenocarcinoma which is… 
1969
1969
Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions.
Review
1967
Review
1967
Gonadal malignancy in gonadal dysgenesis: papillary pseudomucinous cystadenocarcinoma in a patient with Turner's syndrome.
ABSTRACT This report describes a case of papillary pseudomucinous cystadenocarcinoma of the ovary in a patient with Turner's… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)